Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015

被引:0
|
作者
Kumar, Gagan [1 ]
Hererra, Martin [2 ]
Patel, Dhaval [1 ]
Nanchal, Rahul [3 ]
Guddati, Achuta K. [4 ]
机构
[1] Northeast Georgia Hlth Syst, Dept Pulm & Crit Care, Gainesville, GA 30501 USA
[2] Northeast Georgia Hlth Syst, Dept Internal Med, Gainesville, GA 30501 USA
[3] Med Coll Wisconsin, Div Pulm & Crit Care, Milwaukee, WI 53226 USA
[4] Augusta Univ, Dept Hematol & Oncol, Augusta, GA 30912 USA
来源
AMERICAN JOURNAL OF BLOOD RESEARCH | 2020年 / 10卷 / 06期
关键词
Hemophagocytic lymphohistiocytosis; hemophagocytic syndrome; epidemiology; critical illness;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Severe infections caused by the novel coronavirus 2 display similarities to secondary hemophagocytic lymphohistiocytosis (HLH). However, HLH is a rare disease and has not been well described in critically ill patients. Methods: We used the Nationwide Inpatient Sample (NIS), the largest all-payer inpatient care database publicly available in the United States to identify all adult discharges with Hemophagocytic syndrome (ICD-9 CM code 288.4) between 2007 and 2015. Critical illness was considered present if patient had either ICD-9 CM code indicating the requirement of invasive mechanical ventilation or the presence of shock. We used ICD-9-CM codes to identify various infections (inf-HLH), malignancies (mal-HLH) and autoimmune diseases associated with HLH (MAS-HLH) and classified them in their respective groups. Primary outcome was in-hospital mortality in critically ill patients. We developed multivariable regression model to examine variables associated with mortality in critically ill HLH patients. P value was kept at < 0.05. Results: Of the 7420 (95% CI 6959-7881) estimated discharges with HLH, 2313 (31%) were critically ill. Of the critically ill patients, 442 (34%) were mal-HLH, 422 (43.3%) were inf-HLH, 403 (30.7%) were MAS-HLH and 1046 (27.3%) were unable to be classified. In hospital mortality rates were 6.4% in non-critically ill and 48.4% in critically ill patients. Among the subtypes of HLH, in-hospital mortality was 53% in mal-HLH, 49.4% in inf-HLH, 26% in MAS-HLH and 54.6% in unclassified group. On multivariable regression analysis, development of acute renal failure requiring hemodialysis (OR 2.06, 95% CI 1.29-3.3, P=0.002) and acute hepatic failure (OR 2.21, 95% CI 1.38-3.52, P=0.001) were significantly associated with higher mortality. Conclusion: Inpatient mortality of critically ill patients is remarkably high. Patients with MAS-HLH had better outcomes when compared to other groups of HLH.
引用
收藏
页码:330 / +
页数:11
相关论文
共 50 条
  • [21] Descriptive Study of Hemophagocytic Lymphohistiocytosis (HLH) Admissions in Adult Population: Data from Nationwide Inpatient Sample (NIS) Database
    Lingamaneni, Prasanth
    Vohra, Ishaan
    Farooq, Muhammad Zain
    Malapati, Sindhu
    Singh, Sunny R. K.
    BLOOD, 2019, 134
  • [22] Outcomes of dual adult kidney transplants in the United States: An analysis of the OPTN/UNOS database
    Gill, Jagbir
    Cho, Yong W.
    Danovitch, Gabriel M.
    Wilkinson, Alan
    Lipshutz, Gerald
    Pham, Phuong-Thu
    Gill, John S.
    Shah, Tariq
    Bunnapradist, Suphamai
    TRANSPLANTATION, 2008, 85 (01) : 62 - 68
  • [23] Thrombectomy Utilization for Posterior Stroke in The United States: Perspectives from Nationwide Administrative Database
    Pujara, Deep
    Shaker, Faris
    Imam, Bita
    Reddy, Sujan
    Parsha, Kaushik
    Sitton, Clark W.
    Kamal, Haris
    Sarraj, Amrou
    ANNALS OF NEUROLOGY, 2019, 86 : S81 - S82
  • [24] A Retrospective Analysis of 94 Patients with Hemophagocytic Lymphohistiocytosis of Unknown Etiology from a Single Center
    He, Xiaodan
    Wang, Jingshi
    Wang, Zhao
    ONCOLOGIE, 2021, 23 (04) : 559 - 567
  • [25] Demographics, Treatment Outcomes and Resource Utilization Among Patients Hospitalized with Adult Onset Hemophagocytic Lymphohistiocytosis (HLH): A Nationwide Analysis
    Bedi, Prabhjot Singh
    Rai, Manoj P.
    Kandola, Samanjit Kaur
    Kaner, Justin D.
    Mujer, Mark
    Abro, Calvin
    Enofe, Ikponmwosa
    Kavuturu, Shilpa
    Tageja, Nishant
    Laird-Fick, Heather
    Abougergi, Marwan S.
    Bussel, James B.
    Marks, Stanley M.
    BLOOD, 2018, 132
  • [26] OUTCOMES OF HOSPITALIZED PREGNANT IBD PATIENTS IN THE UNITED STATES: INSIGHTS FROM A NATIONAL INPATIENT DATABASE
    Pimpinelli, Marcella
    Bhurwal, Abhishek
    Pimpinelli, Sophia
    Seril, Darren N.
    GASTROENTEROLOGY, 2022, 162 (07) : S637 - S638
  • [27] Outcomes of male breast cancer in the United States: A SEER database analysis from 1973 to 2008
    Hossain, Akm Mosharraf
    Bobba, Ravi Kiran
    Kardinal, Carl G.
    Freter, Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Dexmedetomidine in the Care of Critically Ill Patients from 2001 to 2007 An Observational Cohort Study
    Wunsch, Hannah
    Kahn, Jeremy M.
    Kramer, Andrew A.
    Wagener, Gebhard
    Li, Guohua
    Sladen, Robert N.
    Rubenfeld, Gordon D.
    ANESTHESIOLOGY, 2010, 113 (02) : 386 - 394
  • [29] Top 20 dermatologic conditions affecting adult patients of color in the United States: insights from an All of Us Database analysis
    Chen, Li-Chi
    Kam, Sharon
    Chung, Hye Jin
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [30] THERAPY MODIFICATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH A BIOLOGIC IN THE UNITED STATES - DESCRIPTIVE ANALYSES FROM AN ADMINISTRATIVE CLAIMS DATABASE
    Walsh, J. A.
    Adejoro, O.
    Chastek, B.
    Chun, G.
    Park, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 346 - 346